The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.

Saved in:
Bibliographic Details
Title: The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.
Authors: Levine CR; Cardio-Pulmonary Research Institute and Department of Pediatrics, Winthrop-University Hospital, SUNY-Stony Brook School of Medicine, Mineola, NY 11501, USA., Gewolb IH, Allen K, Welch RW, Melby JM, Pollack S, Shaffer T, Pilon AL, Davis JM
Source: Pediatric research [Pediatr Res] 2005 Jul; Vol. 58 (1), pp. 15-21. Date of Electronic Publication: 2005 Mar 17.
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 0100714 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0031-3998 (Print) Linking ISSN: 00313998 NLM ISO Abbreviation: Pediatr Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0031-3998
DOI:10.1203/01.PDR.0000156371.89952.35